Japan PMDA Market Entry Watch for Medical Devices and IVDs: July 2026

Japan market access planning should start with product classification and a realistic evidence strategy. Medical device and IVD manufacturers should align intended use, technical documentation, clinical or performance evidence, and quality records before committing to a submission route.

What to review

• Product classification, the expected review route, and the evidence required for the intended use.
• Device or IVD performance claims, labelling, risk management, and quality documentation.
• Post-market readiness, including complaint management, safety reporting, and change control.

Practical impact

An early gap review can prevent late changes to claims, evidence plans, or documentation. It also helps ensure that product and quality teams are using consistent information throughout the submission programme.

Source to monitor

Follow PMDA medical device information for Japan regulatory references and updates.